Institut
-
US government HIV/AIDS clinical trial sites to accelerate completion of Phase III TB drug trial
The TB Alliance announces the launch of a collaboration with the National Institute of Allergy and Infectious Diseases’ (NIAID) AIDS Clinical Trial Group (ACTG) to conduct and help complete a Phase III clinical trial testing potentially faster-acting tuberculosis (TB) treatments.
Institut | 09 January 2012
-
Agilent Technologies supports research at the Broad Institute
Developing proteomics technology to detect disease biomarkers.
Institut | 12 October 2011
-
Pharmacyclics collaborates with National Cancer Institute to develop Btk inhibitor
Pharmacyclics, Inc announced the signing of a five-year cooperative research and development agreement (CRADA) with the National Cancer Institute (NCI) to collaborate on the development of PCI-32765. This is a first-in-class, small molecule inhibitor…
Institut | 10 August 2011
-
Merck, Serum Institute to develop and expand access to pneumococcal conjugate vaccine
Merck and Serum Institute of India Limited announced an agreement to work together to develop and commercialize a pneumococcal conjugate vaccine (PCV) for use in the emerging and developing world countries. It is estimated that one out of every two c…
Institut | 04 August 2011
-
Ascletis announces new support from Hangzhou, China and The Hamner Institutes
Ascletis to establish US research and development center at The Hamner Campus.
Institut | 21 July 2011
-
VaxyGen Vaccines announces strategic collaboration with The Serum Institute of India
VaxyGen Vaccines Ltd announced the signing of a strategic collaboration agreement with the Serum Institute of India (SII). Under the terms of the agreement, VaxyGen Vaccines Ltd will have exclusive rights to commercialize certain SII approved and pip…
Institut | 29 June 2011
-
PPD and Southern Research Institute Sign Agreement for Clinical Research Services
PPD and Southern Research Institute have formed a collaborative agreement in pandemic and seasonal influenza vaccine research and development. This is to provide clients a full spectrum of influenza vaccine development services by collaborating on cl…
Institut | 24 March 2010
-
Institut Pasteur Korea and NITD Singapore Collaborate on Tuberculosis Drug Discovery
Institut Pasteur Korea (IPK) and Novartis Institute for Tropical Diseases (NITD), Singapore, have entered into a Services Frame Agreement for the identification of safe and effective new therapies for Tuberculosis infected individuals. This part…
Institut | 23 December 2009
-
A2 Technologies Supports Educational Institutions with Special Priced Spectrometer
A2 Technologies has announced that the Educational Institution Pricing Program on its ML FTIR spectrometer system will continue through to March 31, 2010. This special pricing program allows academic institutions to purchase the ML FTIR spectrometer,…
Institut | 21 December 2009
-
Institut Pasteur Korea to Screen Pfizer Compound Library in Collaboration with DNDi
Institut Pasteur Korea and the Drugs for Neglected Diseases Initiative (DNDi) have entered into a collaborative agreement, centered on the use of Pfizer’s compound library. This is for the identification and development of safe, effective and affor…
Institut | 16 December 2009
